Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Article in Signal Transduction and Targeted Therapy (June 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Signal Transduction and Targeted Therapy (June 2024)
Article in Cancer (February 2024)
Article in Frontiers in Immunology (February 2024)